Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lifshitz Law PLLC Announces Investigations of Celsius Holdings, Inc. (NASDAQ: CELH), Match Group, Inc. (NASDAQ: MTCH), Warner Bros. Discovery, Inc. (NASDAQ: WBD), Dentsply Sirona Inc. (NASDAQ: XRAY)

XRAY, CELH, MTCH, WBD

NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Lifshitz Law Firm

Celsius Holdings, Inc. (NASDAQ:CELH)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose material information. On August 1, 2022, Celsius entered into a long-term distribution agreement with PepsiCo, Inc. ("Pepsi") through which Pepsi would tap into its extensive network of retail and foodservice channels to become the primary distributor of Celsius products in the United States and Celsius' exclusive distributor in Canada. Pepsi also gained the option to become the preferred distribution partner for Celsius in other international markets.

Allegedly, the Company made false and/or misleading statements and/or failed to disclose that: (i) Celsius materially oversold inventory to Pepsi far in excess of demand, and faced a looming sales cliff during which Pepsi would significantly reduce its purchases of Celsius products; (ii) as Pepsi drew down significant amounts of inventory overstock, Celsius' sales would materially decline in future periods, hurting Celsius' financial performance and outlook; (iii) Celsius' sales rate to Pepsi was unsustainable and created a misleading impression of Celsius' financial performance and outlook; (iv) as a result, Celsius' business metrics and financial prospects were not as strong as indicated in the Company's statements; and (v) consequently, the Company's statements regarding Celsius' outlook and expected financial performance were false and misleading.

If you are a CELH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Match Group, Inc. (NASDAQ:MTCH)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Match Group materially understated the challenges affecting its Tinder app and, as a result, understated the risk that Tinder's monthly active user count would not recover by the time that Match Group reported its financial results for the third quarter of 2024; and (ii) as a result, the Company's statements about Match Group's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

If you are a MTCH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Warner Bros. Discovery, Inc. (NASDAQ:WBD)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose: (i) WBD's sports rights negotiations with the NBA were causing, or were likely to cause, the Company to significantly reevaluate its business and goodwill; (ii) WBD's goodwill in its Networks segment had significantly deteriorated as a result of the difference between its market capitalization and book value, continued softness in certain U.S. advertising markets, and uncertainty related to affiliate and sports rights renewals, including with the NBA; (iii) the foregoing significantly increased the likelihood of WBD incurring billions of dollars in goodwill impairment charges; (iv) accordingly, the Company had overstated WBD's overall business and financial prospects; and (v) as a result, the Company's public statements were materially false and misleading.

If you are a WBD investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Dentsply Sirona Inc. (NASDAQ:XRAY)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose: (i) Dentsply targeted low-income people who did not have access to good oral hygiene education, a dentist, or dental insurance, which often meant patients signing up for Byte had underlying dental issues that would have made them ineligible for treatment; (ii) the push for Byte growth and sales commissions caused sales employees to sell to contraindicated patients; (iii) as a result of the above, the Byte patient onboarding workflow did not provide adequate assurance that contraindicated patients did not enter treatment; (iv) reports of Byte patient injuries began pouring in; (v) Dentsply knew that its Byte aligners were causing severe patient injuries for years but did little to investigate those injuries or notify the FDA; (vi) Dentsply had no systems in place to notify the FDA of these injuries, which the Company is required to do within 30 days of learning of a problem; (vii) the FDA had received a sharp uptick in reports of serious injuries from Byte patients; (viii) as a result of the above, Dentsply materially overstated the goodwill value of Byte; and (ix) as a result of the above, the Company's positive statements about the Dentsply Sirona's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

If you are an XRAY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

ATTORNEY ADVERTISING.© 2025 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

CONTACT:
Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376

SOURCE: Lifshitz Law Firm



View the original press release on ACCESS Newswire



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today